Cizzle Biotechnology Share Discussion Threads

[npk2] 14/12/2024 21:16

Looks like you're "the idiot," as you haven't left the LSE site, you're just posting under (one of your many) a new username.So who's the "tool" now then.

[m_night10] 18/11/2024 10:11

POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.

Massive takeover target and will be sold for 20p+ share price.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

[npk2] 07/11/2024 18:00

That's great news. No more reading your whining posts.

[joeb12] 06/11/2024 16:42

Glad I sold at 2.21p.

Will see if it drops further for reentry.

[joeb12] 05/11/2024 17:09

Fizzle.com

[jibba jabber] 23/10/2024 11:55

Zero interest

[ged5] 22/10/2024 09:47

Talking about the people that 'Bio' have brought in Alan says at 4:33 "The sort of group of people you need to have when you've moved from a lab based company into a commercial company actually bringing the tests to market"

Latest interview:-

[npk2] 21/10/2024 18:01

I've done some very rudimentary maths. If you can increase the 5% of eligible people that currently get a scan and increase that to 10% because of a simple blood test, the royalties alone are worth $20m pa to Cizzle.That's starting to catch my imagination.

[dplewis1] 21/10/2024 16:51

The revenues they talk of .. they're not exactly going to get the juices flowing are they.. I can see why it's not caught peoples imagination

[jibba jabber] 21/10/2024 16:11

I've been in for 3 years!

[npk2] 21/10/2024 15:41

Could be a good time to get in then.So under the radar.

[jibba jabber] 21/10/2024 15:03

There's next to zero interest in this share.

[jibba jabber] 21/10/2024 11:14

Falling back? it hasn't even risen

[bones698] 21/10/2024 10:31

20% spread doesn't make this very appealing and likely to fall back when there is little news for long periods . Mms playing games trapping in people who bought on the spike .

[joeb12] 21/10/2024 08:23

Great RNS today.

Opens up expansion into other regions of the world now 🎉🚀

[joeb12] 18/10/2024 21:59

York brings back some fond memories for me back in summer 1992.

Enough said.

[joeb12] 18/10/2024 21:57

Have you seen the Cizzle Bio website and who’s the main people there now ?

[npk2] 18/10/2024 17:33

They did specify timeframes. They're in the RNS announcements.It just so happens that they've missed all of them.

[joeb12] 18/10/2024 11:42

What’s wrong with buying back at a lower price ?

Isn’t it called trading ?

[npk2] 16/10/2024 18:50

There may not be one.You sold at 2.2p and 2.13p.You chose to buyback in.Suck it up big boy and stop bleating.

[joeb12] 16/10/2024 12:27

Why should I sell when the investors haven’t seen the MOU agreement RNS ?

Cizzle BIO should’ve specified a timeframe instead of keeping investors in the dark.